Reported last patient, last visit in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with early-stage dementia with Lewy bodies (DLB) in October 2024; topline data expected ...

For more information, or to sign-up to volunteer, go to https://www.concernedforthehungry.org. Fall-La-Palooza event aims to ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

An unnamed 45-year-old man posted an Ask Me Anything (AMA) thread on Reddit discussing the struggles his wife faces after ...

Most cases of dementia are caused by a mixture of risk factors. A risk factor is something that affects our chances of developing a condition like dementia. For most of us our risk of dementia is made ...

In the UK, people living with certain types of dementia, can be prescribed treatments to help manage their symptoms. These are known as symptomatic treatments. They include donepezil (part of a family ...

Patient characteristics are consistent with other DLB studies -PURCHASE, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, ...

Baseline characteristics of the 130 participants enrolled in the study, as described in the poster: “DLB is one of the most common forms of dementia and a complex neurological condition. Symptoms ...

Exercising only at weekends is just as effective at staving off dementia as regular workouts, according to a study. Scientists have discovered ‘weekend warriors’ are as likely to lower their ...

The posters were not created or installed by the city of New York, and photographs of them were actually from 2018. In October 2024, ahead of the U.S. presidential elections and as Republican ...

For the follow-up Phase 1/2a trial on moderate Alzheimer’s patients, the Company hypothesized that troculeucel, given at the highest dose to date of 6 billion cells, could be safely infused and hopes ...